Humes Jennifer 4

What Happened Jennifer Humes, Chief Accounting Officer of Roivant Sciences Ltd. (ROIV), received equity awards on April 20, 2026: 29,173 restricted stock units (RSUs) and 27,157 stock options (reported as a derivative award). Both grants are reported at $0.00 (they are compensation awards, not open-market purchases or sales).

Key Details

• Transaction date: April 20, 2026; Form 4 filed April 22, 2026 (appears timely).
• Reported consideration: $0.00 for both the RSU award and the option award (typical for equity compensation grants).
• Shares owned after the transaction: Not specified in the provided filing details.
• Footnote F1 (RSUs): Vesting starts April 20, 2026 — 25% vests on the first anniversary, then the remainder vests in 12 equal quarterly installments thereafter, subject to continued service.
• Footnote F2 (options): Vesting starts April 20, 2026 — 25% vests on the first anniversary, then the remainder vests in 36 equal monthly installments thereafter, subject to continued service.

Context These entries are grants of compensation (RSUs and stock options), not purchases or exercises. Such awards typically align employee incentives with shareholder value but do not reflect an immediate cash commitment or sale by the insider. The options grant represents the right to buy shares in the future according to the vesting schedule; RSUs convert to shares as they vest.